missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ EphA2 Antibody (Sanofi Aventis patent anti-EphA2) - Humanized, Novus Biologicals™
Human Monoclonal Antibody
Marca: Novus Biologicals™ NBP3-28354-1mg
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
EphA2 Monoclonal antibody specifically detects EphA2 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Especificaciones
| EphA2 | |
| Monoclonal | |
| Unconjugated | |
| P29317 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| Sanofi Aventis patent anti-EphA2 | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| ARCC2, EC 2.7.10, EC 2.7.10.1, ECKepithelial cell receptor protein tyrosine kinase, EPH receptor A2, EphA2, ephrin type-A receptor 2, Epithelial cell kinase, soluble EPHA2 variant 1, Tyrosine-protein kinase receptor ECK | |
| EphA2 | |
| 1 mg | |
| Cancer, Protein Kinase | |
| 1969 | |
| Human | |
| Purified |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido